Anybody seen this teaser? Thanks
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Anybody seen this teaser? Thanks
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More InfoYour subscription is paid through your PayPal account.
To update your credit card or cancel, please log in to PayPal.com, go to your automatic payments, open the Stock Gumshoe payment, and make changes there.
More information here: Paypal — What Is an Automatic Payment and How Do I Update or Cancel One?
Bio-Science Report, Christmas, FL 16 page color marketing mailer explains how “one tiny biotech company, CTBO, (CantaBio Pharmaceuticals previously Gardedam Pharmaceuticals), may have taken the lead in the all-out race for a cure for Alzheimer’s, Parkinson’s and Dementia… through multiple drug candidates, targeting the DJ-1 Protein”. Using selective compounds CB101 & CB102 and CB201.
Dr. Gergely Toth, PhD Founder and CEO, of Gardedam, Palo Alto, CA in 2009, to present CEO of CantaBio plus consult with two neurodegenerative advisors all with affiliations to University of Cambridge. RECO: Buy up to $5.50.